Revenue
10.4 million USD
2017 Q3 · USD
Exact inputs and evidence
- Revenue: 10406000 USD Source
145 filing records in this dataset, filed from 1995-06-08 to 2018-02-14. Reported financial figures are available; chart coverage varies by period.
10.4 million USD
2017 Q3 · USD
7.22%
2017 Q3 · %
1.64 million USD
2017 Q3 · USD
1.47 million USD
2017 Q3 · USD
7265000 USD
3000000 Unit12
4409088 shares
1.67% · 72.5 thousand shares
Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2018-02-14.
Financial data available through: 2016-10-31.
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Prior period
USD 37.47 million
–
Current period
USD 40.04 million
–
40040000 − 37467000 = 2573000 USD
37467000 USD · 2014-11-01 – 2015-10-31
Inspect prior input Prior source40040000 USD · 2015-11-01 – 2016-10-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
USD 3.98 million
–
Current period
−USD 3.77 million
–
-3774000 − 3976000 = -7750000 USD
3976000 USD · 2014-11-01 – 2015-10-31
Inspect prior input Prior source-3774000 USD · 2015-11-01 – 2016-10-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
USD 2.16 million
–
Current period
USD 4.56 million
–
4562000 − 2158000 = 2404000 USD
2158000 USD · 2014-11-01 – 2015-10-31
Inspect prior input Prior source4562000 USD · 2015-11-01 – 2016-10-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Comparable inputs unavailable for: Capital expenditure.
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
| Period | Revenue | Operating costs | Operating income | Tax, interest and other | Net income | Free cash flow | Source |
|---|---|---|---|---|---|---|---|
| 2006 2005-11-01 – 2006-10-31 | 33651000 | 31552000 Derived | 2099000 | 662000 Derived | 1437000 | Unavailable | Source
|
| 2007 2006-11-01 – 2007-10-31 | 38580000 | 36986000 Derived | 1594000 | 537000 Derived | 1057000 | Unavailable | Source
|
| 2008 2007-11-01 – 2008-10-31 | 30011000 | 30758000 Derived | -747000 | -61000 Derived | -686000 | Unavailable | Source
|
| 2009 2008-11-01 – 2009-10-31 | 25479000 | 27056000 Derived | -1577000 | 16000 Derived | -1593000 | Unavailable | Source
|
| 2015 2014-11-01 – 2015-10-31 | 37467000 | 35864000 Derived | 1603000 | -2373000 Derived | 3976000 | Unavailable | Source
|
| 2016 2015-11-01 – 2016-10-31 | 40040000 | 42657000 Derived | -2617000 | 1157000 Derived | -3774000 | Unavailable | Source
|
Amounts are exact, in USD.
Sales over time and how quickly they are changing.
Revenue reported for each complete financial period.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2006 | Revenue | 33651000 |
|
| 2007 | Revenue | 38580000 |
|
| 2008 | Revenue | 30011000 |
|
| 2009 | Revenue | 25479000 |
|
| 2015 | Revenue | 37467000 |
|
| 2016 | Revenue | 40040000 |
|
Change in revenue from the same financial period one year earlier.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2006 | Year over year | No prior comparable period |
|
| 2007 | Year over year | 14.6% |
|
| 2008 | Year over year | -22.2% |
|
| 2009 | Year over year | -15.1% |
|
| 2015 | Year over year | No prior comparable period |
|
| 2016 | Year over year | 6.9% |
|
How much revenue becomes profit, and how much cash operations generate.
Operating income, net income and free cash flow as a share of revenue.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2006 | Operating margin | 6.2% |
|
| 2007 | Operating margin | 4.1% |
|
| 2008 | Operating margin | -2.5% |
|
| 2009 | Operating margin | -6.2% |
|
| 2015 | Operating margin | 4.3% |
|
| 2016 | Operating margin | -6.5% |
|
| 2006 | Net margin | 4.3% |
|
| 2007 | Net margin | 2.7% |
|
| 2008 | Net margin | -2.3% |
|
| 2009 | Net margin | -6.3% |
|
| 2015 | Net margin | 10.6% |
|
| 2016 | Net margin | -9.4% |
|
| 2006 | Free cash flow margin | Not reported |
|
| 2007 | Free cash flow margin | Not reported |
|
| 2008 | Free cash flow margin | Not reported |
|
| 2009 | Free cash flow margin | Not reported |
|
| 2015 | Free cash flow margin | Not reported |
|
| 2016 | Free cash flow margin | Not reported |
|
Cash generated by the company’s normal business operations.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2006 | Operating cash flow | 2608000 |
|
| 2007 | Operating cash flow | 1489000 |
|
| 2008 | Operating cash flow | 2322000 |
|
| 2009 | Operating cash flow | 2325000 |
|
| 2015 | Operating cash flow | 2158000 |
|
| 2016 | Operating cash flow | 4562000 |
|
Operating cash flow minus capital expenditure for the same period and unit.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2006 | Free cash flow | Unavailable |
|
| 2007 | Free cash flow | Unavailable |
|
| 2008 | Free cash flow | Unavailable |
|
| 2009 | Free cash flow | Unavailable |
|
| 2015 | Free cash flow | Unavailable |
|
| 2016 | Free cash flow | Unavailable |
|
Liabilities and short-term ability to meet obligations at each period end.
Total liabilities as a share of total assets.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2006 | Liabilities / assets | 34.2% |
|
| 2007 | Liabilities / assets | 29% |
|
| 2008 | Liabilities / assets | 24.8% |
|
| 2009 | Liabilities / assets | 26.3% |
|
| 2015 | Liabilities / assets | 44% |
|
| 2016 | Liabilities / assets | 44.8% |
|
Current assets divided by current liabilities.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2006 | Current assets / current liabilities | 2.53× |
|
| 2007 | Current assets / current liabilities | 3.23× |
|
| 2008 | Current assets / current liabilities | 4.07× |
|
| 2009 | Current assets / current liabilities | 3.92× |
|
| 2015 | Current assets / current liabilities | 2.1× |
|
| 2016 | Current assets / current liabilities | 2.24× |
|
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2006 2005-11-01 – 2006-10-31 | USD 1.44 million Exact valueExact value: 1437000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 2.61 million Exact valueExact value: 2608000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2007 2006-11-01 – 2007-10-31 | USD 1.06 million Exact valueExact value: 1057000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 1.49 million Exact valueExact value: 1489000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2008 2007-11-01 – 2008-10-31 | −USD 686,000 Exact valueExact value: -686000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 2.32 million Exact valueExact value: 2322000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2009 2008-11-01 – 2009-10-31 | −USD 1.59 million Exact valueExact value: -1593000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 2.33 million Exact valueExact value: 2325000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2015 2014-11-01 – 2015-10-31 | USD 3.98 million Exact valueExact value: 3976000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 2.16 million Exact valueExact value: 2158000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2016 2015-11-01 – 2016-10-31 | −USD 3.77 million Exact valueExact value: -3774000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 4.56 million Exact valueExact value: 4562000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
145 filings · 2,436 latest values · 2,436 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0000815093, 815093, angn, edgar:815093, mgcd
Also known as ANGEION CORP/MN, MGC DIAGNOSTICS Corp, MGC Diagnostics Corporation